The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View

<p>Abstract</p> <p>Options for the prevention of hereditary breast and ovarian cancer include screening, preventive surgery and chemoprevention. Screening studies with magnetic resonance imaging of the breast are promising but the technology is not widespread and MRI is unlikely to...

Full description

Bibliographic Details
Main Author:	Narod Steven
Format:	Article
Language:	English
Published:	BMC 2004-02-01
Series:	Hereditary Cancer in Clinical Practice
Subjects:	BRCA1 BRCA2 breast cancer ovarian cancer chemoprevention
Online Access:	http://www.hccpjournal.com/content/2/1/5

Similar Items

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
by: Fatima Zahra El Ansari, et al.
Published: (2020-08-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Hereditary female cancers: Breast, ovarian, and endometrial
by: J. Morgan Tucker, III, et al.
Published: (2011-12-01)

THE IMPACT OF GENETIC COUNSELING ON CLINICAL DECISION MAKING AMONG WOMEN EVALUATED FOR HEREDITARY BREAST AND OVARIAN CANCER RISK
by: PRITZLAFF, MARY ELIZABETH
Published: (2001)

Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021-03-01)

The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study
by: Takashi Mitamura, et al.
Published: (2021-02-01)

Spectrum of germline BRCA mutations in hereditary breast and ovarian cancer syndrome in Indian population: A central reference laboratory experience
by: Pratiksha Chheda, et al.
Published: (2020-01-01)

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women
by: Wen-Ming Cao, et al.
Published: (2019-06-01)

Hereditary ovarian cancer
by: I A Demidova
Published: (2015-09-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
by: Yousef M. Hawsawi, et al.
Published: (2019-09-01)

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome
by: Kardashian Ani, et al.
Published: (2012-04-01)

Hereditary breast and ovarian cancer in Andalusian families: a genetic population study
by: Bella Pajares, et al.
Published: (2018-06-01)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
by: Tomasz Kluz, et al.
Published: (2018-02-01)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
by: Arianna Nicolussi, et al.
Published: (2019-04-01)

Prevalence of the <it>BRCA1 </it>founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald Ingrid P, et al.
Published: (2011-12-01)

Screening for BRCA1 and BRCA2 mutations in breast cancer patients from mexico: the public health perspective Tamizaje de BRCA1 y BRCA2 en pacientes con cáncerde mama en méxico: perspectiva de la salud pública
by: Steven A Narod
Published: (2009-01-01)

REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

Ovarian cancer: the Fallopian tube as the site of origin and opportunities for prevention
by: Sophia HL George, PhD, et al.
Published: (2016-05-01)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
by: Krylova Nadezhda, et al.
Published: (2007-09-01)

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Selected Aspects of Molecular Diagnostics of Constitutional Alterations in <it>BRCA1 </it>and <it>BRCA2 </it>Genes Associated with Increased Risk of Breast Cancer in the Polish Population
by: Górski Bohdan
Published: (2006-08-01)

Parental perceptions regarding the disclosure and non-disclosure of hereditary breast and ovarian (HBO) test results to minors
by: Seenandan-Sookdeo, Kendra-Ann I.
Published: (2014)

Characterisation of BRCA1 genomic rearrangements in South African breast and/or ovarian cancer families
by: Reeves, Michelle Diana
Published: (2013)

Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer
by: Hollis RL, et al.
Published: (2017-05-01)

<i>HRness</i> in Breast and Ovarian Cancers
by: Elizabeth Santana dos Santos, et al.
Published: (2020-05-01)

The contribution of breastfeeding to the prevention of breast cancer
by: Sofia Dimou, et al.
Published: (2019-11-01)

Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw
by: Dominik Olejniczak, et al.
Published: (2016-03-01)

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
by: Patricia Ashton-Prolla, et al.
Published: (2014-01-01)

THE EFFECT OF CLINICAL PRACTICE LOCATION ON PHYSICIAN REFERRAL PRACTICES AND ATTITUDES FOR HEREDITARY BREAST CANCER
by: KREKEL, CHRISTINE ELIZABETH
Published: (2002)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
by: Metcalfe Kelly A, et al.
Published: (2005-04-01)

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
by: Christoph Engel, et al.
Published: (2018-03-01)

A Clinical Trial to Increase the Identification, Genetic Counseling Referral and Genetic Testing of Women at risk for Hereditary Breast and/or Ovarian Cancer
by: Ceceilia Bellcross, et al.
Published: (2017-07-01)

Guidelines for complex genetic analysis of hereditary breast ovarian cancer syndrome in slovak population
by: Konecny M, et al.
Published: (2015-12-01)

Genetic Variants in the 3’UTR of <i>BRCA1</i> and <i>BRCA2 </i>Genes and their Putative Effects on the microRNA Mechanism in Hereditary Breast and Ovarian Cancer
by: María Marisela Sánchez-Chaparro, et al.
Published: (2020-05-01)

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer
by: Møller Pål
Published: (2004-12-01)

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)